DNA damage-induced apoptosis: insights from the mouse

被引:17
作者
Zabkiewicz, J [1 ]
Clarke, AR [1 ]
机构
[1] Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2004年 / 1705卷 / 01期
关键词
p53; mismatch repair; apoptosis; murine model; tumorigenesis; clonogenic survival; mutation;
D O I
10.1016/j.bbcan.2004.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The availability of murine models with precisely defined genetic lesions has greatly increased our understanding of the genetic control of cell death, with functional dependence established for a wide range of genes including (amongst others) the p53 and Bcl-2 gene family members, the mismatch repair (MMR) genes and the methyl binding domain family member Mbd4. These studies raised the attractive hypotheses that tumour predisposition may be explained in terms of failed cell death, and also that tumour regression may be initiated through activation of an apoptotic programme. The studies that have addressed these notions have revealed complex consequences of a failed death programme, such that these simple hypotheses have not always been supported. Remarkably, however, some tissues show more predictable responses than others, most apparent in the contrast between the intestine and the haematopoietic system. This review will focus upon a discussion of these relationships, and will also consider the relevance of some of these findings to tumour predisposition and regression. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 78 条
[61]   The ability to engage enterocyte apoptosis does not predict long-term crypt survival in p53 and Msh2 deficient mice [J].
Sansom, OJ ;
Clarke, AR .
ONCOGENE, 2002, 21 (38) :5934-5939
[62]   Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner [J].
Sansom, OJ ;
Toft, NJ ;
Winton, DJ ;
Clarke, AR .
ONCOGENE, 2001, 20 (27) :3580-3584
[63]   Dissecting p53 tumor suppressor functions in vivo [J].
Schmitt, CA ;
Fridman, JS ;
Yang, M ;
Baranov, E ;
Hoffman, RM ;
Lowe, SW .
CANCER CELL, 2002, 1 (03) :289-298
[64]  
Schmitt CA, 1999, J PATHOL, V187, P127
[65]   Genetic analysis of chemoresistance in primary murine lymphomas [J].
Schmitt, CA ;
Rosenthal, CT ;
Lowe, SW .
NATURE MEDICINE, 2000, 6 (09) :1029-1035
[66]   Fas-associated death domain protein interacts with methyl-CpG binding domain protein 4: A potential link between genome surveillance and apoptosis [J].
Screaton, RA ;
Kiessling, S ;
Sansom, OJ ;
Millar, CB ;
Maddison, K ;
Bird, A ;
Clarke, AR ;
Frisch, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (09) :5211-5216
[67]   Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice [J].
Shao, CS ;
Yin, MY ;
Deng, L ;
Stambrook, PJ ;
Doetschman, T ;
Tischfield, JA .
ONCOGENE, 2002, 21 (18) :2840-2845
[68]   Integral role of Noxa in p53-mediated apoptotic response [J].
Shibue, T ;
Takeda, K ;
Oda, E ;
Tanaka, H ;
Murasawa, H ;
Takaoka, A ;
Morishita, Y ;
Akira, S ;
Taniguchi, T ;
Tanaka, N .
GENES & DEVELOPMENT, 2003, 17 (18) :2233-2238
[69]   Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin [J].
Shimodaira, H ;
Yoshioka-Yamashita, A ;
Kolodner, RD ;
Wang, JYJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2420-2425
[70]   To die or not to die: how does p53 decide? [J].
Slee, EA ;
O'Connor, DJ ;
Lu, X .
ONCOGENE, 2004, 23 (16) :2809-2818